TeselaGen Stock

TeselaGen is accelerating the design and fabrication of DNA with synthetic biology software.

Sign up today and learn more about TeselaGen Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About TeselaGen Stock

TeselaGen is building a rapid prototyping system for fast bio-based construction of sustainably sourced chemicals, therapeutic medicines, and novel vaccines. Their customers are biopharmaceutical and bioindustrial companies like Amgen and Genomatica. Their bioCAD/CAM system is based on technology exclusively licensed from Lawrence Berkeley National Lab and is being beta tested by hundreds of users.


Founder and Chief Scientific Officer

Nathan Hillson

Founder & CEO

Michael Fero

Founder & CTO

Eduardo Abeliuk

Team Member

Nick Elsbree


EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: